MoneyWorks4Me

Colinz Laboratories - Quaterly Results

31 Jan 2022 Evaluate
The revenue for the December 2021 quarter is pegged at Rs. 15.91 millions, about 6.21% up against Rs. 14.98 millions recorded during the year-ago period.The company almost doubled its revenue to Rs. 0.88 millions  from Rs. 0.29 millions in the quarter ended December 2021.Operating profit surged to 1.84 millions from the corresponding previous quarter of 1.11 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 15.91 14.98 6.21 53.92 45.22 19.24 61.59 76.03 -18.99
Other Income 0.29 0.29 0.00 0.99 1.19 -16.81 1.91 1.35 41.48
PBIDT 1.84 1.11 65.77 5.71 3.89 46.79 5.22 4.38 19.18
Interest 0.23 0.25 -8.00 0.62 0.62 0.00 0.87 0.67 29.85
PBDT 1.61 0.86 87.21 5.09 3.27 55.66 4.35 3.71 17.25
Depreciation 0.51 0.49 4.08 1.51 1.41 7.09 1.91 1.95 -2.05
PBT 1.10 0.37 197.30 3.58 1.86 92.47 2.44 1.76 38.64
TAX 0.22 0.08 175.00 0.87 0.38 128.95 0.38 0.46 -17.39
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.40 -0.24 66.67
PAT 0.88 0.29 203.45 2.71 1.48 83.11 2.06 1.30 58.46
Equity 45.71 45.71 0.00 45.71 45.71 0.00 35.44 35.44 0.00
PBIDTM(%) 11.57 7.41 56.07 10.59 8.60 23.10 8.48 5.76 47.12
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..